Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Xiongwen Tang
Shanghai Junshi Biosciences Co., LTD
Shanghai
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
123
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Axitinib in Combination with Toripalimab, a Humanized IgG4 mAb Against Programmed Death-1 (PD-1) in Patients with Metastatic Mucosal Melanoma: A Non-Randomized, Open-Label, Dose-Finding, and Cohort-Expansion Phase 1b Trial
Number of pages: 148
Posted: 24 Jan 2019
Xinan Sheng
,
Xieqiao Yan
,
Zhihong Chi
,
Lu Si
,
Chuanliang Cui
,
Bixia Tang
,
Siming Li
,
Lili Mao
,
Bin Lian
,
Xuan Wang
,
Xue Bai
,
Li Zhou
,
Yan Kong
,
Jie Dai
,
Kai Wang
, Xiongwen Tang,
Huaning Zhou
,
Hai Wu
,
Hui Feng
,
Sheng Yao
,
Keith T. Flaherty
and
Jun Guo
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Inc., Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Harvard University - Harvard Medical School and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads
123
(486,928)
Citation
1
View PDF
Download
Abstract:
Mucosal, Melanoma, anti-PD-1 antibody, Axitinib
Feedback
